Cantor Fitzgerald Reiterates Overweight on Roivant Sciences, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Roivant Sciences (NASDAQ:ROIV) and maintained a $15 price target.
September 18, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Roivant Sciences has received an Overweight rating from Cantor Fitzgerald, with a maintained price target of $15.
The Overweight rating from Cantor Fitzgerald indicates a positive outlook for Roivant Sciences. The maintained price target of $15 suggests that the analyst believes the stock is undervalued at its current price, which could lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100